This piece breaks down EssilorLuxottica, the eyewear giant behind Ray-Ban and Oakley. The investor argues its real moat isn't brand pricing power (gross margin 63%, not high) but vertical integration (makes and sells its own products) plus an open architecture (also sells competitors' goods in its stores), creating a virtuous cycle of scale. However, its 20% EBIT margin target may be delayed due to reinvestments in smart glasses and hearing aids. Three key holdings: Ray-Ban (smart glasses sold 2 million units), Oakley (dominant in sports eyewear), and Supreme (acquired for $1.5B, possibly to target younger consumers with smart glasses, but logic is questionable).
This edition's guest is Swetha Ramachandran (manager of the Artemis Leading Consumer Brands strategy and the Global Select/Global Focus strategies). She systematically deconstructs the business model, competitive moats, and growth prospects of EssilorLuxottica. Core conclusion: The company's true moat is not brand pricing power (gross margin of 63% vs. the more common 80%+), but rather vertical integration combined with an open architecture—where competitors are also its customers—creating a positive scale loop. However, the 20% EBIT margin target may be delayed due to reinvestment in areas such as smart glasses.
Swetha Ramachandran emphasizes that EssilorLuxottica spans two distinctly different markets: vision correction (75% of revenue) is a medical necessity, less affected by economic cycles; while frames and sunglasses (25%) are closer to fashion consumption and subject to cyclical fluctuations. The company generated approximately €26.5 billion in revenue in 2024, but reached only about 113 million consumers (based on an average price of €200), whereas the global myopic population already exceeds 2 billion and is expected to reach 5 billion by 2050, leaving enormous room for penetration growth. Emerging markets (particularly the rising incidence of childhood myopia in Asia) are a long-term structural growth driver.
Data support: In 2024, the company produced 550 million pairs of prescription lenses, covering roughly 5% of the global population; nearly 90% of visual impairments remain undiagnosed in developing economies. The company's gross margin is approximately 63%-64%, stable over the past five years, but management has not guided for significant improvement, as growth in lower-margin channels such as insurance business will offset gains from price-mix improvements. R&D accounts for only 2% of sales, yet already exceeds that of 75% of industry peers, demonstrating the ability to invest in innovation under scale effects.
Swetha believes that the 2018 merger of Essilor and Luxottica was a marriage of "innovation" and "branding," but governance conflicts nearly destroyed the integration value. Essilor invented progressive lenses in 1959 and holds over 12,000 patents; Luxottica excels at revitalizing dormant brands like Ray-Ban. After the merger, Luxottica founder Del Vecchio and Essilor chairman Saniere engaged in a three-year power struggle, until a settlement in 2019 that established a co-CEO and deputy CEO structure. This process severely damaged the stock price and investor confidence.
Subsequent acquisitions: In 2019, it acquired GrandVision (Europe's largest optical retailer) for approximately EUR 7 billion. Although the EU required the sale of 350 stores, it filled Essilor's gap in direct retail. In 2024, it acquired the Supreme streetwear brand from VF Corp for USD 1.5 billion, a price lower than VF's original purchase price. Swetha believes the logic of this acquisition is questionable — unless used to promote smart glasses targeting younger consumers, it would be just "selling hats and T-shirts" and a waste of shareholder money.
Swetha points out that the market generally believes eyewear is an "exorbitant profit" business, but EssilorLuxottica's pricing power is actually moderate, far below luxury goods (e.g., LVMH's gross margin exceeds 80%) and also above sportswear (Nike/Adidas around 50%). The stability of the 63% gross margin stems from scale and vertical integration, not monopoly pricing. The company's selling expenses account for about half of gross profit (an ~16% selling expense ratio), as it operates approximately 18,000 retail stores and employs 200,000 people; advertising costs account for 7% of sales, and general administrative expenses account for 8% (relatively high due to operations in 150 countries). Capital expenditure is steady at around 5%, of which one-third is used for retail renovation, one-third for operations, and 20% for digitalization (including e-commerce, which currently accounts for only 7% of sales).
EBIT margin is about 16%, and management targets 19%-20% by 2026, but Swetha believes this may be delayed, as new businesses such as smart glasses and hearing aids (Nuance technology) require significant reinvestment. She specifically notes that the company aims to achieve a 20% profit margin by the end of 2026, but the priority is growth rather than profit margin, so this target is "likely to be delayed."
Swetha uses Warby Parker as an example to illustrate the limitations of the "pure DTC model." Warby Parker's $1.5 billion in revenue is only about 2% of EssilorLuxottica's, and it has yet to achieve stable profitability. Its single-brand, North America-focused, outsourced production model has become a disadvantage in the post-pandemic era, where consumers seek multi-brand choices. In contrast, EssilorLuxottica, with over 150 brands, a global retail network, and an "open architecture"—selling competitors' products in its own stores (e.g., Kering Eyewear's Gucci sunglasses, Hoya's lenses)—has achieved a virtuous cycle of scale and customer loyalty. This dynamic where "competitors are also customers" (e.g., Hoya is both a competing brand and a major customer) is absent in other vertically integrated companies (e.g., Inditex's Zara does not sell H&M).
Antitrust risk: Swetha believes that EssilorLuxottica holds only a 33% share of the frames and sunglasses market, with 40% of the market occupied by non-large enterprises, indicating no dominant position. In the prescription lens market, it holds a 55% share, but gross margins are not high, and innovative products (e.g., Stellest myopia-control lenses) can command a reasonable premium, with no evidence of pricing power abuse. Therefore, the risk of material threats from the FTC or DOJ is low.
Swetha believes that the Ray-Ban Meta smart glasses (launched in October 2023) are the only smart glasses product to achieve mass-market adoption, with 2 million units sold (unit price ~$300), and the company is expanding production capacity to 10 million units per year. The key factor is the integration of Meta AI, which makes the functionality far superior to the previous generation Ray-Ban Stories. However, Swetha also points out that EssilorLuxottica does not own the AI technology, and the partnership model makes its success highly dependent on the competitiveness of Meta AI; it may face threats from giants like Apple launching superior products in the future. In addition, the Supreme acquisition may pave the way for smart glasses to appeal to younger demographics, though success in the Asian market remains uncertain.
Hearing assistance: By acquiring the technology of Israeli startup Nuance, the company has launched a glasses-based solution for mild to moderate hearing loss, priced at approximately $1,500 (OTC, out-of-pocket). This is expected to leverage the aging trend and new channels (over-the-counter in the US, opticians in Europe) to open up a new market.
| Ticker | Guest View | Key Data |
|---|---|---|
| Ray-Ban | Bullish (successful brand reinvention, key vehicle for smart eyewear) | Acquired in 1999 for $640M, now annual revenue >€3B; Meta Ray-Ban sold 2M units |
| Oakley | Bullish (dominant in sports eyewear) | Acquired in 2007 for $2.1B |
| Supreme | Neutral (acquisition logic questionable, may be used for smart eyewear to attract younger consumers) | Acquired in 2024 from VF Corp for $1.5B, below VF's purchase price |
| Warby Parker | Risk Warning (profitability challenges, scale only 2% of competitor) | Revenue ~2% of EssilorLuxottica, has not achieved stable profitability |
| Meta | Neutral (cooperation necessary, but technology risk remains) | Approved to hold up to 5% stake (unconfirmed), AI-driven smart eyewear success |
| Hoya | Neutral (both competitor and customer) | Major competitor in prescription lenses, but also a customer of EssilorLuxottica |
| Carl Zeiss | Neutral (another oligopolistic competitor) | Forms an oligopoly alongside Hoya |
| Alcon | Risk Warning (only occupies a small segment of the value chain) | Closest competitor, but scale only 1/3 of EssilorLuxottica |
| Céphilo | Neutral (not acquired, market share ~7%) | Luxottica considered acquisition but abandoned the idea |
| Kering Eyewear | Neutral (competitor, but also a customer) | Holds licenses for brands such as Gucci, sells in EssilorLuxottica stores |
| GrandVision | Bullish (fills European retail gap) | Acquired in 2019 for ~€7B, required to divest 350 stores |
| Nuance (Israeli startup) | Bullish (hearing aid technology) | Glasses form factor addresses mild-to-moderate hearing loss, priced ~$1,500, plans OTC sales in the US |
1. Vertical integration + open architecture is a unique moat (Swetha): Competitors (e.g., Hoya, Kering Eyewear) also sell products through EssilorLuxottica's retail network. This "openness" differs from closed systems like Zara, allowing the company to achieve both scale and customer loyalty.
2. Smart glasses success depends on Meta AI, not the glasses themselves (Swetha): The company does not own AI technology, and the partnership model makes its growth highly dependent on Meta's competitiveness; if Apple or others launch superior products, the first-mover advantage could be eroded.
3. The 20% EBIT margin target is likely to be delayed (Swetha): Management prioritizes investment in smart glasses and hearing aid growth over margin expansion; history shows that capital expenditure (7% → 5% steady state) and retail expansion will continue to consume cash.
4. Pricing power is moderate, not excessive (Swetha): The 63% gross margin is stable but far below luxury goods (80%+), and market fragmentation (40% of the eyewear frame market consists of non-large enterprises) limits pricing power; consumers have ample alternatives.
5. Emerging market penetration is the biggest long-term variable (Swetha): The company covers only 113 million consumers, while the global myopic population is expected to reach 5 billion by 2050; childhood myopia rates in Asia are extremely high, but the current share of independent retail channels is low, requiring reliance on e-commerce and owned stores.
6. A double-edged sword of family control (Swetha): Del Vecchio's long-term vision (e.g., turning Ray-Ban from a discarded brand into €3 billion in revenue over 15 years) is an advantage, but governance conflicts (2018-2021) also led to a depressed stock price and damaged investor confidence.
7. The logic behind the Supreme acquisition may lie in rejuvenating smart glasses (Swetha): If it were only for selling apparel, $1.5 billion would be wasteful; but if used to launch Supreme-branded smart glasses to attract Asian and Gen Z consumers, it would be strategically meaningful.
8. Antitrust risk is low because the market definition is sufficiently broad (Swetha): The company's 33% market share in frames and 55% in prescription lenses has not led to obvious pricing power abuse; moreover, the open architecture (selling competitors' products) reduces regulatory scrutiny.